.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Accenture
US Department of Justice
Mallinckrodt
Julphar
Dow
Colorcon
Express Scripts
Fish and Richardson

Generated: September 23, 2017

DrugPatentWatch Database Preview

NORETHINDRONE ACETATE Drug Profile

« Back to Dashboard

Which patents cover Norethindrone Acetate, and what generic Norethindrone Acetate alternatives are available?

Norethindrone Acetate is a drug marketed by Aurobindo Pharma Ltd, Barr, Amneal Pharms, Mylan Labs Ltd, Glenmark Generics, Barr Labs Inc, Mayne Pharma, and Glenmark Pharms Ltd. and is included in twenty NDAs.

The generic ingredient in NORETHINDRONE ACETATE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for Tradename: NORETHINDRONE ACETATE

Patents:0
Applicants:8
NDAs:20
Suppliers / Packagers: see list9
Bulk Api Vendors: see list58
Clinical Trials: see list953
Patent Applications: see list1,981
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NORETHINDRONE ACETATE at DailyMed

Pharmacology for Tradename: NORETHINDRONE ACETATE

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
NORETHINDRONE ACETATE
norethindrone acetate
TABLET;ORAL204236-001Jan 8, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ethinyl estradiol; norethindrone acetate
TABLET, CHEWABLE;ORAL207514-001Sep 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-28076629-001Mar 18, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
NORETHINDRONE ACETATE
norethindrone acetate
TABLET;ORAL205278-001Nov 10, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone acetate
TABLET;ORAL207260-001Feb 2, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ethinyl estradiol; norethindrone acetate
TABLET;ORAL202742-001Oct 30, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone acetate
TABLET;ORAL203038-001Apr 2, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr Labs Inc
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ethinyl estradiol; norethindrone acetate
TABLET;ORAL090938-001Dec 1, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-28202772-001Nov 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21202770-001Feb 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Mallinckrodt
Merck
Medtronic
Queensland Health
Chubb
Dow
Chinese Patent Office
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot